- A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Berkenblit, A., Matulonis, U.A., Kroener, J.F., Dezube, B.J., Lam, G.N., Cuasay, L.C., Brünner, N., Jones, T.R., Silverman, M.H., Gold, M.A. Gynecol. Oncol. (2005)